Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Perturbations in beta-cell heterogeneity in the pathogenesis of type 2 diabetes

Using single-cell transcriptomics and functional assays, we identified various subsets of pancreatic beta cells. One subset, characterized by high levels of CD63, demonstrated enhanced glucose metabolism, mitochondrial activity, and glucose-induced insulin secretion, and the proportion of these beta cells was decreased in mouse models of type 2 diabetes (T2D) and humans with T2D.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Identification and characterization of metabolically active beta cells.


  1. Gutierrez, G. D., Gromada, J. & Sussel, L. Heterogeneity of the pancreatic beta cell. Front. Genet. 8, 22 (2017). A review article summarizing beta-cell functional and morphological heterogeneity.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Benninger, R. K. P. & Kravets, V. The physiological role of beta-cell heterogeneity in pancreatic islet function. Nat. Rev. Endocrinol. 18, 9–22 (2022). A review article describing the features of beta-cell subpopulations in terms of insulin secretion, focusing on studies employing single-cell omics analyses and fluorescent reporters.

  3. Knudsen, J. G. & Rorsman, P. Beta cell dysfunction in type 2 diabetes: drained of energy? Cell Metab. 29, 1–2 (2019). A review article summarizing mechanisms of beta-cell dysfunction in T2D.

    Article  CAS  PubMed  Google Scholar 

  4. Dominguez-Gutierrez, G., Xin, Y. & Gromada, J. Heterogeneity of human pancreatic beta-cells. Mol. Metab. 27S, S7–S14 (2019). A review discussing the limitations of performing single-cell transcriptomics in human pancreatic islet cell samples.

    Article  PubMed  Google Scholar 

  5. Mawla, A. M. & Huising, M. O. Navigating the depths and avoiding the shallows of pancreatic islet cell transcriptomes. Diabetes 68, 1380–1393 (2019). In this article, the authors conduct a comprehensive meta-analysis with several data sets of human single-beta-cell transcriptomes.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Rubio-Navarro, A. et al. A beta cell subset with enhanced insulin secretion and glucose metabolism is reduced in type 2 diabetes. Nat. Cell Biol. (2023).

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perturbations in beta-cell heterogeneity in the pathogenesis of type 2 diabetes. Nat Cell Biol 25, 524–525 (2023).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing